Status:
UNKNOWN
Conformation of Beta Human Chorionic Gonadotropin During Chemotherapy for Choriocarcinoma
Lead Sponsor:
National Taiwan University Hospital
Collaborating Sponsors:
National Science and Technology Council, Taiwan
Conditions:
Trophoblastic Neoplasms
Choriocarcinoma
Eligibility:
FEMALE
Brief Summary
Gestational trophoblastic disease comprises a spectrum of diseases with different propensity for local invasion and metastasis, that is, partial and complete hydatidiform mole, choriocarcinoma, and pl...
Detailed Description
The conformational change of human chorionic gonadotropin beta (hCG beta) during chemotherapy for gestational trophoblastic disease and its clinical meaning have not been well understood. In this stud...
Eligibility Criteria
Inclusion
- Clinical diagnosis of trophoblastic neoplasms
- Willing to be collected for the urine and 2 ml blood samples
Exclusion
- Unwilling to be collected for the collect urine or 2ml blood sample
Key Trial Info
Start Date :
August 1 2006
Trial Type :
OBSERVATIONAL
End Date :
July 1 2008
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT00294177
Start Date
August 1 2006
End Date
July 1 2008
Last Update
February 20 2006
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Taiwan University Hospital Department of Obstetrics and Gynecology
Taipei, Taipei, Taiwan, 100